Facebook
X
LinkedIn
ForwardModule III: Frontiers in Neurology and Brain Health
Module III: Neuropsychiatric and neurodegenerative disorders are at an all time high and one of the leading causes of disability worldwide. This Neurology module details the neuropsychological components of a systems biology approach to the brain and peripheral nervous systems. For example, recent developments in psychoneuroimmunology and the Gut-Neuro-Endocrine axis have defined the critical relationships between the brain and all bodily systems at the cellular and sub-cellular levels. The role of neuroinflammation and its relation to microbes, metals and other exposures on brain health will also be explored. Cutting edge treatments such as lipid therapy, the Bredesen Protocol, hyperbaric oxygen treatment, peptides, nutritional approaches, and regenerative therapies is covered.
Target Audience
This activity is intended to meet the educational needs of the healthcare team including but not limited to:
- Physicians
- Residents
- Medical Students
- Pharmacists
- Physician assistants
- Nurses
- Other Healthcare Professionals
Learning Objectives
After participating in this activity, learners will be able to:
- Recognize the parameters within the Functional Medicine Matrix that would indicate the need for attention to neurotransmitter function.
- Discuss the role of early child-hood trauma on the physiological functions of the Neuro-Endocrine-Immune system.
- Describe the role of microbes, metals, and other exposures on the development of neurological disorders.
- Examine the role of neuroinflammation in neurodegenerative and neuropsychiatric conditions.
- Discuss cutting edge anti-aging and functional medicine treatment modalities in common neurological disorders.
Disclosure of Relevant Financial Relationships
In accordance with The Standards for Integrity and Independence, GW requires all planners, faculty, and others in control of educational content to disclose the absence or existence of all financial relationships (of any dollar amount) with any ineligible companies within the past 24 months. We define ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
GW reviews all disclosure statements to determine which financial relationships are relevant to the educational content of the CE Activity. An individual is considered to have a relevant financial relationship if the educational content an individual can control is related to the business lines or products of the ineligible company.
Disclosure Statement(s)
Relevant Financial Relationships
Upon review of all collected information about financial relationships with ineligible companies, GW has determined that the following planners, faculty, and others in control of educational content have relevant financial relationships with ineligible companies.
An individual is considered to have a relevant financial relationship if the educational content an individual can control is related to the business lines or products of the ineligible company.
- Faculty member Rafael Gonzalez, PhD discloses the following relationships: TheBioBox, LLC, RESTEM, LLC, Gentera Med, L-Nutra
- Faculty member Dayan Goodenowe, PhD discloses the following relationships: Prodrome Sciences
- Faculty member Charles Argoff, MD discloses the following relationships: Abbvie, Averitas, Nevro, Vertex, Clexio
- Faculty member Jeffrey Becker, MD discloses the following relationships: Bexson Biomedical Inc., Neurohacker Collective
- Faculty member Wade Cooper, DO discloses the following relationships: Dolor Technologies, Eli Lily, Biohaven, Teva, Impel
- Faculty member Sabine Hazan, MD discloses the following relationships: Progenabiome
- Faculty member Sheldon Jordan, MD discloses the following relationships: Synaptec Companies
- Faculty member Sahar Swidan, PharmD, BCPS, ABAAHP discloses the following relationships: Amgen and Biohaven
- Faculty member Dale Bredesen, MD discloses the following relationships: Apollo Health, Life Seasons
All relevant financial relationships listed for these individual(s) have been mitigated.
All others in a position to control content for this educational activity have no relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Disclaimer
The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The George Washington University.
Accreditation Statements
The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement(s)
Physicians (CME)
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The George Washington University School of Medicine and Health Sciences and The American Academy of Anti-Aging Medicine. The George Washington University School of Medicine and Health Sciences is accredited by the ACCME to provide continuing medical education for physicians.
The George Washington University School of Medicine and Health Sciences designates this enduring activity for a maximum of 24 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Osteopathic Association (AOA)
The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Osteopathic Association (AOA) recognizes AMA PRA Category 1 Credit™ earned as AOA Category 2 credit.
It is the physician's responsibility to report CME credits earned directly to AOA.
Ways to report CME Credit:
- Email: Your CME Certificate to Physician Education & CME at [email protected].
- Online: Via the CME Self-Reporting Tool (login required).
Other Healthcare Professionals (Attendance)
All other healthcare professionals who successfully complete the activity will receive a Certificate of Attendance. Many credentialing bodies such as the ANCC, AANP, and AAPA accept certificates of attendance for educational activities certified for AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME. If you have doubts about whether an activity will qualify for CE, please contact your certifying organization for clarification on credit eligibility.
Available Credit
- 24.00 AMA PRA Category 1 Credit™The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
- 24.00 Completion
Registration Instructions
Please note that you must be logged in to complete the CE credit claim process.
New Users
You must create a learner account prior to claiming CE credit.
Click here to create a learner account
Click here to access additional instructions for creating a learner account